ANIK · Anika Therapeutics, Inc.
One customer — 53% of revenue (the three months ended June 30, 2026)
“Revenue from the Company’s sole significant customer, Johnson & Johnson MedTech (“J&J MedTech”), part of the Johnson & Johnson Medical Companies, as a percentage of the Company’s total revenue was 53% and 50% for the three-months ended June 30, 2026, and 2025, respectively, and 50% for the six-months ended June 30, 2026, and 2025.”
One customer — 50% of revenue (the six months ended June 30, 2026)
“Revenue from the Company’s sole significant customer, Johnson & Johnson MedTech (“J&J MedTech”), part of the Johnson & Johnson Medical Companies, as a percentage of the Company’s total revenue was 53% and 50% for the three-months ended June 30, 2026, and 2025, respectively, and 50% for the six-months ended June 30, 2026, and 2025.”
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-11-05 | $15,000,000 | $0 | 2026-04-10 | 2026-06-30 expired | 8-K , filed 2026-04-29 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-06-30 YTD | $9,543,000 | 10-Q, filed 2026-07-29 |
| 2025-12-31 | $9,485,000 | 10-K, filed 2026-03-03 |
| 2024-12-31 | $10,914,000 | 10-K, filed 2026-03-03 |
| 2023-12-31 | $5,000,000 | 10-K, filed 2026-03-03 |
| 2022-12-31 | $0 | 10-K, filed 2025-03-17 |
| 2021-12-31 | $0 | 10-K, filed 2024-03-15 |
| 2020-12-31 | $0 | 10-K, filed 2022-03-11 |
| 2019-12-31 | $30,000,000 | 10-K, filed 2022-03-11 |
| 2018-12-31 | $30,000,000 | 10-K/A, filed 2021-04-26 |
| 2016-12-31 | $25,000,000 | 10-K, filed 2019-02-27 |